UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) – Stock analysts at Oppenheimer issued their Q1 2024 earnings per share (EPS) estimates for shares of UnitedHealth Group in a research report issued on Thursday, January 19th. Oppenheimer analyst M. Wiederhorn forecasts that the healthcare conglomerate will post earnings of $7.11 per share for the quarter. The consensus estimate for UnitedHealth Group’s current full-year earnings is $24.82 per share. Oppenheimer also issued estimates for UnitedHealth Group’s Q2 2024 earnings at $7.07 EPS, Q3 2024 earnings at $7.18 EPS, Q4 2024 earnings at $6.79 EPS and FY2025 earnings at $31.79 EPS.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating the consensus estimate of $5.17 by $0.17. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The firm had revenue of $82.79 billion for the quarter, compared to analyst estimates of $82.53 billion. During the same quarter in the prior year, the company posted $4.48 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.3% compared to the same quarter last year.
UnitedHealth Group Price Performance
UNH stock opened at $486.72 on Friday. The company has a current ratio of 0.77, a quick ratio of 0.82 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average of $519.23 and a 200-day moving average of $524.27. UnitedHealth Group has a 12-month low of $445.73 and a 12-month high of $558.10. The company has a market cap of $454.77 billion, a price-to-earnings ratio of 22.97, a PEG ratio of 1.35 and a beta of 0.73.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date was Friday, December 2nd. UnitedHealth Group’s payout ratio is currently 31.15%.
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 616 shares of the stock in a transaction dated Friday, December 2nd. The stock was sold at an average price of $535.00, for a total value of $329,560.00. Following the transaction, the executive vice president now owns 8,463 shares of the company’s stock, valued at $4,527,705. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.40% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the company. Virtus ETF Advisers LLC purchased a new stake in UnitedHealth Group in the second quarter worth about $718,000. Octavia Wealth Advisors LLC increased its position in UnitedHealth Group by 8.8% in the second quarter. Octavia Wealth Advisors LLC now owns 740 shares of the healthcare conglomerate’s stock worth $380,000 after buying an additional 60 shares in the last quarter. Arcus Capital Partners LLC grew its position in shares of UnitedHealth Group by 40.1% during the third quarter. Arcus Capital Partners LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,241,000 after purchasing an additional 703 shares in the last quarter. Great Valley Advisor Group Inc. grew its position in shares of UnitedHealth Group by 41.8% during the second quarter. Great Valley Advisor Group Inc. now owns 26,614 shares of the healthcare conglomerate’s stock worth $13,670,000 after purchasing an additional 7,851 shares in the last quarter. Finally, Crumly & Associates Inc. grew its position in shares of UnitedHealth Group by 2.5% during the second quarter. Crumly & Associates Inc. now owns 1,578 shares of the healthcare conglomerate’s stock worth $810,000 after purchasing an additional 38 shares in the last quarter. Institutional investors own 86.31% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.